Coronary disease & ACSRandomised controlled trial

Percutaneous Coronary Intervention (PCI) of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery

J Am Coll CardiolPublished

  • Randomised controlled trial
  • multicentre
  • 14 centres in Europe
  • Long-term follow-up ongoing

Authors' conclusion

In the randomized PROCTOR trial, SVG PCI was associated with improved 1-year clinical outcomes compared with native vessel PCI, primarily driven by lower rates of PCI-related MI and clinically driven target coronary territory revascularization.

Study context

Population
Post-CABG patients with significant saphenous vein graft (SVG) stenosis/failure and a heart team-defined indication for revascularization
Participants
220 patients
Comparison
Native vessel PCI vs SVG PCI
  • Native vessel PCIn = 108
  • SVG PCIn = 112reference
Primary endpoint
Major adverse cardiac events:
  • All-cause mortality
  • Nonfatal target coronary territory myocardial infarction (MI)
  • Clinically driven target coronary territory revascularization
Follow-up
1 year after index PCI

Primary result

Major adverse cardiac events · 1 year

Hazard ratio

2.14

95% CI 1.25–3.65

P = 0.006

Events by treatment group

Native vessel PCI vs SVG PCI
HR 2.14 (95% CI 1.25–3.65); P = 0.006

As reported in the abstract

Further findings

OutcomeHR (95% CI)P value
All-cause mortality · 1 year · no significant difference1.59 (0.45–5.64)P = 0.472
Nonfatal target coronary territory MI · 1 year2.12 (1.08–4.17)P = 0.029
Clinically driven target coronary territory revascularization · 1 year2.19 (1.02–4.72)P = 0.044

Safety

OutcomeNative vessel PCISVG PCIHR (95% CI)P value
PCI-related MI13%1%14.85 (1.95–112.96)P = 0.009

Original publication

PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery. J Am Coll Cardiol. Published 28 October 2025. doi:10.1016/j.jacc.2025.09.1577

Summarised from the published abstract; every number is checked against it